The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data.
J Urol
; 203(4): 743-750, 2020 Apr.
Article
in En
| MEDLINE
| ID: mdl-31580749
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Testosterone
/
Gonadotropin-Releasing Hormone
/
Antineoplastic Agents, Hormonal
/
Medication Adherence
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
J Urol
Year:
2020
Type:
Article